New York, NY, United States of America

Youyi Peng


 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • New York, NY (US) (2015 - 2018)
  • Plainsboro, NJ (US) (2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Youyi Peng

Introduction

Youyi Peng is a notable inventor based in New York, NY, who has made significant contributions to the field of organic compounds. With a total of six patents to his name, his work focuses on developing compounds and methods that address various medical conditions.

Latest Patents

Among his latest patents, one relates to organic compounds that function as nicotinic receptor antagonists. This invention provides methods of treatment that block the activity of certain acetylcholine receptors, which can be beneficial in treating diseases such as diabetes mellitus, chronic kidney disease, and acute kidney failure. Another patent involves novel compounds and methods for inhibiting CK1, which are aimed at treating disorders like Alzheimer's disease by administering a therapeutically effective amount of a CK1 inhibitor.

Career Highlights

Youyi Peng is currently associated with Intra-Cellular Therapies, Inc., where he continues to innovate in the field of pharmaceuticals. His research and inventions have the potential to significantly impact the treatment of various health conditions.

Collaborations

He has collaborated with notable colleagues, including Lawrence P. Wennogle and Qiang Zhang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Youyi Peng's work exemplifies the spirit of innovation in the field of organic compounds, with his patents paving the way for advancements in medical treatments. His contributions are invaluable to the scientific community and hold promise for improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…